| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.5 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.5 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |